sarpogrelate has been researched along with Blood Clot in 6 studies
sarpogrelate: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| " We give an overview of several new antiplatelet agents that are currently investigated in secondary stroke prevention: adenosine 5'-diphosphonate receptor antagonists, cilostazol, sarpogrelate, terutroban and SCH 530348." | 4.86 | Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention. ( Diener, HC; Weber, R, 2010) |
| "Ticlopidine was significantly effective only at 100 mg/kg p." | 1.28 | Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease. ( Hara, H; Kitajima, A; Shimada, H; Tamao, Y, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weber, R | 1 |
| Diener, HC | 1 |
| Yamada, K | 1 |
| Niki, H | 1 |
| Nagai, H | 1 |
| Nishikawa, M | 1 |
| Nakagawa, H | 1 |
| Nishihira, K | 1 |
| Yamashita, A | 1 |
| Tanaka, N | 1 |
| Kawamoto, R | 1 |
| Imamura, T | 1 |
| Yamamoto, R | 1 |
| Eto, T | 1 |
| Asada, Y | 1 |
| Takase, MT | 1 |
| Hashimoto, I | 1 |
| Nakanishi, H | 1 |
| Nakaya, Y | 1 |
| Harada, H | 1 |
| Sedo, H | 1 |
| Kanda, I | 1 |
| Hara, H | 2 |
| Kitajima, A | 2 |
| Shimada, H | 2 |
| Tamao, Y | 2 |
1 review available for sarpogrelate and Blood Clot
| Article | Year |
|---|---|
Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention.
Topics: Aspirin; Blood-Brain Barrier; Cilostazol; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy | 2010 |
5 other studies available for sarpogrelate and Blood Clot
| Article | Year |
|---|---|
Serotonin potentiates high-glucose-induced endothelial injury: the role of serotonin and 5-HT(2A) receptors in promoting thrombosis in diabetes.
Topics: Animals; Aspirin; Cells, Cultured; Cilostazol; Diabetes Mellitus, Experimental; Fibrinolytic Agents; | 2012 |
Inhibition of 5-hydroxytryptamine receptor prevents occlusive thrombus formation on neointima of the rabbit femoral artery.
Topics: Animals; Arterial Occlusive Diseases; Catheterization; Disease Models, Animal; Femoral Artery; Fibri | 2006 |
Sarpogrelate hydrochloride, an antagonist of 5-hydroxytryptamine receptor, improves skin flap survival and suppresses thrombus formation in injured microvessels of rabbits.
Topics: Animals; Arterioles; Cell Adhesion; Ear; Graft Survival; Leukocytes; Male; Microcirculation; Rabbits | 2006 |
Antithrombotic effect of MCI-9042, a new antiplatelet agent on experimental thrombosis models.
Topics: Animals; Electric Stimulation; Fibrinolytic Agents; Male; Mesenteric Arteries; Mice; Mice, Inbred St | 1991 |
Effect of (+/-)-2-(dimethylamino)-1-[[o-(m-methoxyphenethyl)phenoxy] methyl]ethyl hydrogen succinate on experimental models of peripheral obstructive disease.
Topics: Animals; Arterial Occlusive Diseases; Carrageenan; Fibrinolytic Agents; Infarction; Lauric Acids; Ma | 1991 |